Brussels + 32.2.645.14.27

Luca Salernitano advises international clients on EU and national regulatory matters in the life sciences arena, particularly involving pharmaceuticals, medical devices, cosmetics, and food products. He assists companies in the entire lifecycle of products, from early development stages, to manufacturing, marketing, and post-marketing issues.

Luca has significant litigation and dispute resolution experience before the Court of Justice of the European Union as well as Italian courts. He also has worked on corporate/transactional, product liability, and data privacy matters.

Luca has spoken at national and international events on pharmaceuticals and food products and has contributed to articles regarding pharmaceutical regulations.


  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.